Primary study · included by 4 reviews
Expression of Vascular Endothelial Growth Factor Using Platelet Rich Fibrin (PRF) and Nanohydroxyapatite (nano-HA) in Treatment of Periodontal Intra-Bony Defects - A Randomized Controlled Trial.
Bahammam 2021 · Bahammam Maha A, Attia Mai S · Saudi journal of biological sciences · 2021
Included by
The review does not say which of its outcomes this study informs.
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Clinical attachment level or relative attachment level gain (mm) Regenerative periodontal therapy with autologous platelet-concentrate adjunct (PRF, CGF, i-PRF, A-PRF, T-PRF) vs Regenerative periodontal therapy without platelet concentrate (graft only, OFD or other) · Follow-up 6 to 12 months (varied across studies) | MD 0.64 [0.38, 0.90] | 10 studies · 259 participants | GRADE not reported |
Clinical attachment level or relative attachment level gain (mm) Regenerative periodontal therapy with autologous platelet-concentrate adjunct (PRF, CGF, i-PRF, A-PRF, T-PRF) vs Regenerative periodontal therapy without platelet concentrate (graft only, OFD or other) · Follow-up 6 to 12 months (varied across studies) | MD 0.35 [0.08, 0.61] | 8 studies · 200 participants | GRADE not reported |
The review does not say which of its outcomes this study informs.
The review does not say which of its outcomes this study informs.
4 including reviews in total.